Direct-acting antivirals trump interferon-alpha in their capacity to rescue exhausted T cells upon HCV clearance

Journal of Hepatology

Volumn 61, Issue 3, 2014, Pages 459-461

  Maini, Mala K ^a   Schurich, Anna ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; DIRECT ACTING ANTIVIRAL; EPITOPE; UNCLASSIFIED DRUG;

ANTIVIRAL THERAPY; CD8+ T LYMPHOCYTE; DRUG EFFICACY; EDITORIAL; HEPATITIS C; HEPATITIS C VIRUS; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; IMMUNOCOMPETENT CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRAL CLEARANCE; DRUG EFFECTS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; MALE; PHYSIOLOGY;

ANTIVIRAL AGENTS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE;

EID: 84906323538     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.06.017     Document Type: Editorial

References (20)

1. B. Martin, N. Hennecke, V. Lohmann, A. Kayser, C. Neumann-Haefelin, and G. Kukolj et al. Restoration of HCV-specific CD8+ T-cell function by interferon-free therapy J Hepatol 61 2014 538 543
2. E.J. Wherry T cell exhaustion Nat Immunol 12 2011 492 499
3. P. Klenerman, and A. Hill T cells and viral persistence: lessons from diverse infections Nat Immunol 6 2005 873 879
4. S.H. Park, and B. Rehermann Immune responses to HCV and other hepatitis viruses Immunity 40 2014 13 24
5. B. Rehermann Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells Nat Med 19 2013 859 868
6. G.J. Webster, S. Reignat, D. Brown, G.S. Ogg, L. Jones, and S.L. Seneviratne et al. Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy J Virol 78 2004 5707 5719
7. S.N. Mueller, and R. Ahmed High antigen levels are the cause of T cell exhaustion during chronic viral infection Proc Natl Acad Sci U S A 106 2009 8623 8628
8. D.T. Utzschneider, A. Legat, S.A. Fuertes Marraco, L. Carrie, I. Luescher, and D.E. Speiser et al. T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion Nat Immunol 14 2013 603 610
9. P.A. Knolle, and R. Thimme Hepatic immune regulation and its involvement in viral hepatitis infection Gastroenterology 146 2014 1193 1207
10. M.S. Abdel-Hakeem, N. Bedard, G. Badr, M. Ostrowski, R.P. Sekaly, and J. Bruneau et al. Comparison of immune restoration in early vs. late alpha interferon therapy against hepatitis C virus J Virol 84 2010 10429 10435
11. G. Missale, M. Pilli, A. Zerbini, A. Penna, L. Ravanetti, and V. Barili et al. Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection Gut 61 2012 1076 1084
12. E. Barnes, H.C. Gelderblom, I. Humphreys, N. Semmo, H.W. Reesink, and M.G. Beld et al. Cellular immune responses during high-dose interferon-alpha induction therapy for hepatitis C virus infection J Infect Dis 199 2009 819 828
13. B. Bengsch, B. Seigel, M. Ruhl, J. Timm, M. Kuntz, and H.E. Blum et al. Coexpression of PD-1, 2B4, CD160, and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation PLoS Pathog 6 2010 e1000947
14. P.M. Odorizzi, and E.J. Wherry Immunology. An interferon paradox Science (New York, NY) 340 2013 155 156
15. R.M. Welsh, K. Bahl, H.D. Marshall, and S.L. Urban Type 1 interferons and antiviral CD8 T-cell responses PLoS Pathog 8 2012 e1002352
16. A. Penna, D. Laccabue, I. Libri, T. Giuberti, S. Schivazappa, and A. Alfieri et al. Peginterferon-alpha does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis J Hepatol 56 2012 1239 1246
17. C. Boni, D. Laccabue, P. Lampertico, T. Giuberti, M. Vigano, and S. Schivazappa et al. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues Gastroenterology 143 2012 e969
18. L. Micco, D. Peppa, E. Loggi, A. Schurich, L. Jefferson, and C. Cursaro et al. Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B J Hepatol 58 2012 225 233
19. D. Peppa, U.S. Gill, G. Reynolds, N.J. Easom, L.J. Pallett, and A. Schurich et al. Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion J Exp Med 210 2013 99 114
20. B. Seigel, B. Bengsch, V. Lohmann, R. Bartenschlager, H.E. Blum, and R. Thimme Factors that determine the antiviral efficacy of HCV-specific CD8(+) T cells ex vivo Gastroenterology 144 2013 426 436